Elsevier Builds Upon Solution Suite that Provides Greater Insight into the Quality of Care Delivery and the Business of Healthcare

Beta of new ‘clinical insight engine,’ set for April launch, to be demoed at HIMSS12; ClinicalKey joins Elsevier’s analytics and business intelligence, drug information, care planning and clinical documentation, and ICD-10 transition planning tools at Booth #4530

Philadelphia, PA, February 20, 2012 – As healthcare organizations strive to improve quality and efficiency through the smarter use of healthcare information, Elsevier will unveil the newest member of its multidisciplinary solution suite – ClinicalKey – at HIMSS12, the annual conference and exhibition of the Healthcare Information and Management Systems Society (HIMSS), Feb. 20–24, 2012, in Las Vegas.

ClinicalKey, a “clinical insight engine” with Elsevier’s Smart Content at its core, joins Elsevier’s Pinpoint Solutions, Gold Standard Drug Database, CPM CarePoints and Revenue Cycle eLearning tools as the principle component of its advanced clinical decision support solutions suite.

“At HIMSS12, we’ll be showcasing how our valued clients improve the efficiency and quality of care delivery, and the business of care, through these advanced solutions,” said Jay Katzen, Managing Director, Elsevier CDS. “By providing trusted, more comprehensive content to clinicians faster – in addition to evidence-based clinical guidance, drug decision support, business intelligence and revenue cycle management training – we’re able to help healthcare organizations achieve greater quality on all sides of their enterprises.”

Elsevier will be highlighting several key solutions at HIMSS12:

  1. Clinical Insights – ClinicalKey Beta, Elsevier’s new clinical insight engine, leverages Elsevier’s comprehensive, trusted medical content to quickly deliver relevant clinical answers when and where physicians need them.
  2. Analytics and Business Intelligence –Elsevier’s clinical analytics suite, Pinpoint Solutions, unlocks healthcare data, empowering healthcare organizations to make sound clinical and financial decisions.
  3. Roadmap to ICD-10 – With the 2013 CMS conversion deadline looming, Elsevier’s ICD‑10 resources provide the roadmap for successful planning and implementation, and then helps execute that roadmap by providing cross-facility preparation and training.
  4. Smarter Medication Decisions – For help with everything from prescribing and dispensing to administration and reimbursement of medications, the Gold Standard Drug Database delivers the most current and accurate drug data and decision support engine available.
  5. EHR-ready, Evidence-Based Care Plans – With CPM CarePoints, providers can address Meaningful Use and Accountable Care with rapid, easy EHR content design and build, along with value-added transformation support.

“By providing insight and information for all aspects of healthcare, including resource and performance management, care delivery, cost and evidence-based medicine, we are helping clinicians and healthcare administrators make better, more informed decisions for patient care,” said Michael Hansen, CEO of Elsevier Health Sciences. “These solutions enhance clinical workflow without disruption and ultimately lead to better predictability and better outcomes.”

For more information about Elsevier at HIMSS12, visit www.clinicaldecisionsupport.com/HIMSS12 or stop by Booth #4530.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).


Media contact
Christopher Capot
+ 1 203 379 8019
ccapot@knbpr.com